The FDA Group's Insider Newsletter

The FDA Group's Insider Newsletter

4 Best Practices for Preventing CRLs in Biologics Manufacturing

Coinciding with more BLAs in recent years, CDER is handing out more CRLs related to manufacturing issues. Here are a few ways to prevent one yourself.

The FDA Group's avatar
The FDA Group
Aug 27, 2024
∙ Paid

A new report in RAPS sheds light on the increase in BLAs coupled with a rise in CRLs issued by the CDER. CDER Director Patrizia Cavazzoni presented this information at a meeting on biologics and bios…

User's avatar

Continue reading this post for free, courtesy of The FDA Group.

Or purchase a paid subscription.
© 2026 The FDA Group, LLC · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture